Shufro Rose & CO LLC Ovid Therapeutics Inc. Transaction History
Shufro Rose & CO LLC
- $1.22 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding OVID
# of Institutions
75Shares Held
39.2MCall Options Held
10.3KPut Options Held
200-
Rubric Capital Management LP New York, NY5.32MShares$5.95 Million0.12% of portfolio
-
Madison Avenue Partners, LP New York, NY4.08MShares$4.57 Million0.53% of portfolio
-
Black Rock Inc. New York, NY3.99MShares$4.47 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$4.32 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.09MShares$3.46 Million0.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $78.9M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...